HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 3KY for the last semiannual is 842.62 M EUR, and it's 20.23% higher compared to the previous semiannual. The net income of H1 24 is 353.02 M EUR.